USP37 and neoplasm: Moreover, our in vivo experiments, using subcutaneous xenograft models, reinforced these findings by showing that USP37 knockdown in SW1990 cells led to significantly reduced tumor growth, whereas USP37 overexpression in PANC-1 cells resulted in enhanced tumor size and weight.